This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180430005852/en/
Technavio has published a new market research report on the global point-of-care coagulation testing market from 2018-2022. (Graphic: Business Wire)
The growing focus toward personalized medicine is a key trend, which is expected to impact the market. Determination of coagulation in blood is crucial to developing personalized medicine as it provides profiles of individual patients. Additionally, diagnosis and resolution of blood disorders such as VTE can be done through coagulation testing.
In this report, Technavio analysts highlight the growing geriatric population as a key factor contributing to the growth of the global point-of-care coagulation testing market:
Growing geriatric population
The aging population is gradually increasing across the globe. In 2015, people above 65 years represented approximately 7%-8% of the global population. During the forecast period, the aging population is estimated to grow by 50%-55%. Approximately 1.2-1.4 billion people are expected to be above 65 by 2030.
According to a senior analyst at Technavio for research, “The prevalence of diseases such as lung diseases, cancer, and stroke is high among people above 65 years as aging increases the immune system’s susceptibility to infections. The reduced functioning of organs also increases the chances of acquiring infections. These infections lead to blood coagulation disorders, which are detected through blood coagulation testing. Thus, the demand for POC coagulation analyzers is high from the geriatric population.”
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Global point-of-care coagulation testing market
In 2017, the hospitals and clinics segment had a market share of more than 74%. The Americas was the leading region for the global point-of-care coagulation testing market in 2017, accounting for a market share of over 54% followed by EMEA and APAC. APAC will account for the maximum increase in its market shares over the forecast period, while the market share of the other two regions is expected to witness a slight dip.
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180430005852/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: SENIORS HEALTH MEDICAL DEVICES CONSUMER GENERAL HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 04/30/2018 10:38 AM/DISC: 04/30/2018 10:38 AM